PREOPANC-4 Implementation Program for Locally Advanced Pancreatic Cancer

RecruitingOBSERVATIONAL
Enrollment

223

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2030

Conditions
Pancreatic CancerLocally Advanced Pancreatic AdenocarcinomaPancreatic Adenocarcinoma Non-resectableChemotherapy Effect
Interventions
OTHER

Implementation - International best-practice care

The PREOPANC-4 project aims to safely implement the international standard of excellence for LAPC management and surgery using a multidisciplinary best-practice training program, based on the experiences of four leading international expert centers (i.e. NYU Langone Health, University of Colorado, Heidelberg University, and MD Anderson Cancer Center). We hypothesize that the PREOPANC-4 implementation project will result in the improvement in multidisciplinary patient management and selection in line with current international best-practice.

Trial Locations (1)

1105 AZ

RECRUITING

Amsterdam UMC, locatie AMC, Amsterdam

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

UMC Utrecht

OTHER

collaborator

Erasmus Medical Center

OTHER

collaborator

Leiden University Medical Center

OTHER

collaborator

University Medical Center Groningen

OTHER

collaborator

Radboud University Medical Center

OTHER

collaborator

Maastricht University Medical Center

OTHER

collaborator

Medisch Spectrum Twente

OTHER

collaborator

Isala

OTHER

collaborator

Frisius Medisch Centrum

OTHER

collaborator

Onze Lieve Vrouwe Gasthuis

OTHER

collaborator

Amphia ziekenhuis

UNKNOWN

collaborator

Jeroen Bosch Ziekenhuis

OTHER

collaborator

Catharina Ziekenhuis Eindhoven

OTHER

collaborator

University of Colorado, Denver

OTHER

collaborator

Heidelberg University

OTHER

collaborator

M.D. Anderson Cancer Center

OTHER

collaborator

NYU Langone Health

OTHER

collaborator

Dutch Cancer Society

OTHER

collaborator

Maag Lever Darm Stichting

OTHER

collaborator

Deltaplan Alvleesklierkanker

UNKNOWN

lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER